Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2025
Provided By GlobeNewswire
Last update: Jul 10, 2025
Hot Line Presentation of MAPLE-HCM to Elaborate on Positive Topline Results in Patients with Obstructive Hypertrophic Cardiomyopathy
Late Breaking Clinical Science Session to Present Incidence and Impact of Atrial Fibrillation Across Three Clinical Trials of Aficamten in Obstructive Hypertrophic Cardiomyopathy
Read more at globenewswire.com
